Julius Centre University of Malaya, Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
PLoS One. 2012;7(9):e46365. doi: 10.1371/journal.pone.0046365. Epub 2012 Sep 28.
The prevalence of metabolic syndrome is increasing disproportionately among the different ethnicities in Asia compared to the rest of the world. This study aims to determine the differences in the prevalence of metabolic syndrome across ethnicities in Malaysia, a multi-ethnic country.
In 2004, we conducted a national cross-sectional population-based study using a stratified two-stage cluster sampling design (N = 17,211). Metabolic syndrome was defined according to the International Diabetes Federation/National Heart, Lung and Blood Institute/American Heart Association (IDF/NHLBI/AHA-2009) criteria. Multivariate models were used to study the independent association between ethnicity and the prevalence of the metabolic syndrome.
The overall mean age was 36.9 years, and 50.0% participants were female. The ethnic distribution was 57.0% Malay, 28.5% Chinese, 8.9% Indian and 5.0% Indigenous Sarawakians. The overall prevalence of the metabolic syndrome was 27.5%, with a prevalence of central obesity, raised triglycerides, low high density lipoprotein cholesterol, raised blood pressure and raised fasting glucose of 36.9%, 29.3%, 37.2%, 38.0% and 29.1%, respectively. Among those <40 years, the adjusted prevalence ratios for metabolic syndrome for ethnic Chinese, Indians, and Indigenous Sarawakians compared to ethnic Malay were 0.81 (95% CI 0.67 to 0.96), 1.42 (95% CI 1.19 to 1.69) and 1.37 (95% CI 1.08 to 1.73), respectively. Among those aged ≥40 years, the corresponding prevalence ratios were 0.86 (95% CI 0.79 to 0.92), 1.25 (95% CI 1.15 to 1.36), and 0.94 (95% CI 0.80, 1.11). The P-value for the interaction of ethnicity by age was 0.001.
The overall prevalence of metabolic syndrome in Malaysia was high, with marked differences across ethnicities. Ethnic Chinese had the lowest prevalence of metabolic syndrome, while ethnic Indians had the highest. Indigenous Sarawakians showed a marked increase in metabolic syndrome at young ages.
与世界其他地区相比,亚洲不同种族之间代谢综合征的流行率不成比例地增加。本研究旨在确定马来西亚不同种族之间代谢综合征的流行率差异,马来西亚是一个多民族国家。
2004 年,我们采用分层两阶段聚类抽样设计(N=17211)进行了全国性横断面人群研究。代谢综合征根据国际糖尿病联合会/美国国立心肺血液研究所/美国心脏协会(IDF/NHLBI/AHA-2009)标准定义。采用多变量模型研究种族与代谢综合征患病率之间的独立关系。
总体平均年龄为 36.9 岁,50.0%的参与者为女性。种族分布为 57.0%的马来人、28.5%的中国人、8.9%的印度人和 5.0%的沙捞越土著人。代谢综合征的总体患病率为 27.5%,中心性肥胖、甘油三酯升高、高密度脂蛋白胆固醇降低、血压升高和空腹血糖的患病率分别为 36.9%、29.3%、37.2%、38.0%和 29.1%。在<40 岁的人群中,与马来族相比,华裔、印度裔和沙捞越土著居民患代谢综合征的调整后患病率比分别为 0.81(95%可信区间 0.67 至 0.96)、1.42(95%可信区间 1.19 至 1.69)和 1.37(95%可信区间 1.08 至 1.73)。在年龄≥40 岁的人群中,相应的患病率比分别为 0.86(95%可信区间 0.79 至 0.92)、1.25(95%可信区间 1.15 至 1.36)和 0.94(95%可信区间 0.80 至 1.11)。种族与年龄的交互作用 P 值为 0.001。
马来西亚代谢综合征的总体患病率较高,不同种族之间存在显著差异。华裔的代谢综合征患病率最低,而印度裔的患病率最高。沙捞越土著居民在年轻时代谢综合征的发病率显著增加。